Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study

Clinical trial NCT04827056 · COMPLETED

Trial details

NCT number: NCT04827056
Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alcohol Use Disorder (AUD)Post Traumatic Stress Disorder (PTSD)

Start date: 2021-11-09
Primary completion: 2023-05-02
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.